Abstract:DNA copy number variations (CNVs) are a significant and ubiquitous source of human genetic variation. However, the influence of CNVs on cancer susceptibility remains poorly understood. Out of 83 genome-wide association studies (GWAS) on cancer to date, only a few studies found significant associations on germline CNVs and cancer. Here we analyzed data from our ongoing two-stage GWAS of four North American case-control studies to test the hypothesis that CNVs in germline DNA from peripheral blood lymphocytes may serve as risk factors for epithelial ovarian cancer (EOC). To reduce disease heterogeneity, we focused on the subset of cases with serous histology. The analysis was therefore based on 942 serous ovarian cancer patients and 1,682 healthy controls who were genotyped using the Illumina 610K quad array. Subjects with extreme noise and genomic waviness in log R ratio (LR) were excluded prior to segmentation; principal component analysis was performed to adjust for batch effects. CNV segmentation was performed on LR data from 22 autosomes using circular binary segmentation embedded in the Copy Number Analysis Module from Golden Helix SNP Variation Suite version 7. Copy number segment covariates were discretized based on the thresholds that signify a transition between copy number states (deletion/no deletion; duplication/no duplication) after the segmentation. Unconditional logistic regression on a log-additive model was used to evaluate the association between copy number states and serous EOC risk after adjusting for study sites. By comparing single marker copy number states at 388,958 SNPs on 22 autosomes, we observed a total of 134 SNPs significantly associated with risk of serous EOC with a p value below 10 −6 . Associations with deletion polymorphisms were observed on chromosomes 7, 8, 14, and 18 when controlling for false discovery rate at 1%; no duplication polymorphisms were significant. We observed a large deletion at chromosome 14 that occurred in 8.9% of cases but in only 3.9% of controls, with a p value of 5.59×10 −8 (Odds Ratio (OR): 2.56, 95% confidence interval (CI): 1.82-3.60). Another common deletion on chromosome 7 occurred in 8.8% of cases and only 4.3% of controls (p=3.83×10 −6 ; OR: 2.23, 95% CI: 1.60-3.10). Two additional regions on chromosomes 8 and 18 with deletion events less than 5% were also identified. Women who harbored the deletion on chromosome 8 were at lower risk of developing serous ovarian cancer (p=4.83×10 −8 ; OR: 0.04, 95% CI: 0.01-0.30). Women who carried the deletion on chromosome 18 had an increased risk for serous EOC (p=9.04×10 −7 ; OR: 7.26, 95% CI: 2.94-17.97). Further validation of these four regions using independent data sets is currently underway. In summary, this is the largest reported genome-wide study of CNVs and serous EOC risk. These preliminary results suggested that germline CNVs may play an important role in ovarian cancer susceptibility. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1649. doi:1538-7445.AM2012-1649

Additional File 8: of Genomic Copy Number Variation Association Study in Caucasian Patients with Nonsyndromic Cryptorchidism

Accuracy Of Cnv Detection From Gwas Data

Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Genome-Wide Association Study Of Copy Number Variations In Serous Epithelial Ovarian Cancer Susceptibility

Additional File 5: of SeqCNV: a Novel Method for Identification of Copy Number Variations in Targeted Next-Generation Sequencing Data

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Rare copy number variants in over 100,000 European ancestry subjects reveal multiple disease associations

Whole Genome Distribution and Ethnic Differentiation of Copy Number Variation in Caucasian and Asian Populations.

Copy number variation analysis based on AluScan sequences

Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome

CNVbase: Batch Identification of Novel and Rare Copy Number Variations Based on Multi-Ethnic Population Data.

Additional File 7: of CloneCNA: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

Additional File 2: of Evaluation of Three Read-Depth Based CNV Detection Tools Using Whole-Exome Sequencing Data

Additional File 2: Table S2-S4. of Genome-wide Identification of Copy Number Variations Between Two Chicken Lines That Differ in Genetic Resistance to Marek’s Disease

Comprehensive Assessment of Somatic Copy Number Variation Calling Using Next-Generation Sequencing Data

SgD-CNV, a database for common and rare copy number variants in three Asian populations.

Evaluation of Copy Number Variant Detection from Panel‐based Next‐generation Sequencing Data

Common Copy Number Variation Detection From Multiple Sequenced Samples

A large-scale survey of genetic copy number variations among Han Chinese residing in Taiwan

Translational Study of Copy Number Variations in Schizophrenia